Argent Trust CO Pfizer Inc Transaction History

Argent Trust CO

$2.39 Billion
Q3 2024

A detailed history of Argent Trust CO transactions in Pfizer Inc stock. As of the latest transaction made, Argent Trust CO holds 220,975 shares of PFE stock, worth $5.69 Million. This represents 0.27% of its overall portfolio holdings.

Number of Shares

220,975

Previous 227,467 2.85%

Holding current value

$5.69 Million

Previous $6.36 Million 0.49%

% of portfolio

0.27%

Previous 0.28%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$27.7 - $31.39 $179,828 - $203,783	-6,492 Reduced 2.85%	220,975 $6.4 Million
Q2 2024 Aug 12, 2024	SELL	$25.26 - $29.6 $33,999 - $39,841	-1,346 Reduced 0.59%	227,467 $6.36 Million
Q1 2024 May 10, 2024	SELL	$25.89 - $29.73 $185,191 - $212,658	-7,153 Reduced 3.03%	228,813 $6.35 Million
Q4 2023 Feb 09, 2024	SELL	$26.13 - $33.94 $1.48 Million - $1.93 Million	-56,802 Reduced 19.4%	235,966 $6.79 Million
Q3 2023 Nov 08, 2023	SELL	$32.09 - $37.51 $72,748 - $85,035	-2,267 Reduced 0.77%	292,768 $9.71 Million
Q2 2023 Aug 11, 2023	BUY	$36.12 - $41.79 $1.33 Million - $1.54 Million	36,737 Added 14.22%	295,035 $10.8 Million
Q1 2023 May 12, 2023	BUY	$39.39 - $51.28 $225,232 - $293,219	5,718 Added 2.26%	258,298 $10.5 Million
Q4 2022 Feb 10, 2023	BUY	$41.75 - $54.5 $347,276 - $453,331	8,318 Added 3.41%	252,580 $12.9 Million
Q3 2022 Nov 10, 2022	BUY	$43.76 - $53.42 $243,305 - $297,015	5,560 Added 2.33%	244,262 $10.7 Million
Q2 2022 Aug 11, 2022	BUY	$46.53 - $55.17 $529,650 - $628,000	11,383 Added 5.01%	238,702 $12.5 Million
Q1 2022 May 11, 2022	BUY	$45.75 - $56.69 $604,769 - $749,385	13,219 Added 6.17%	227,319 $11.8 Million
Q4 2021 Feb 09, 2022	SELL	$41.32 - $61.25 $149,991 - $222,337	-3,630 Reduced 1.67%	214,100 $12.6 Million
Q3 2021 Nov 09, 2021	SELL	$39.25 - $50.42 $352,779 - $453,174	-8,988 Reduced 3.96%	217,730 $9.36 Million
Q2 2021 Aug 09, 2021	SELL	$35.91 - $40.68 $20,073 - $22,740	-559 Reduced 0.25%	226,718 $8.88 Million
Q1 2021 May 12, 2021	SELL	$33.49 - $37.77 $1 Million - $1.13 Million	-29,994 Reduced 11.66%	227,277 $8.23 Million
Q4 2020 Feb 11, 2021	SELL	$33.47 - $42.56 $185,055 - $235,314	-5,529 Reduced 2.1%	257,271 $9.47 Million
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $140,779 - $165,166	-4,434 Reduced 1.66%	262,800 $9.65 Million
Q2 2020 Aug 04, 2020	SELL	$30.12 - $36.54 $884,865 - $1.07 Million	-29,378 Reduced 9.9%	267,234 $8.74 Million
Q1 2020 May 11, 2020	SELL	$27.03 - $38.62 $175,208 - $250,334	-6,482 Reduced 2.14%	296,612 $9.68 Million
Q4 2019 Feb 11, 2020	BUY	$32.92 - $37.36 $629,035 - $713,874	19,108 Added 6.73%	303,094 $11.9 Million
Q3 2019 Nov 12, 2019	SELL	$32.49 - $42.13 $377,468 - $489,466	-11,618 Reduced 3.93%	283,986 $10.2 Million
Q2 2019 Aug 13, 2019	BUY	$36.98 - $41.52 $55,137 - $61,906	1,491 Added 0.51%	295,604 $12.8 Million
Q1 2019 May 15, 2019	SELL	$37.5 - $41.2 $228,225 - $250,743	-6,086 Reduced 2.03%	294,113 $12.5 Million
Q4 2018 Feb 06, 2019	BUY	$38.47 - $43.86 $2.25 Million - $2.56 Million	58,362 Added 24.13%	300,199 $13.1 Million
Q3 2018 Nov 14, 2018	SELL	$34.47 - $41.81 $32,574 - $39,510	-945 Reduced 0.39%	241,837 $10.5 Million
Q2 2018 Apr 15, 2019	BUY	$32.98 - $35.16 $167,175 - $178,226	5,069 Added 2.13%	242,782 $8.81 Million
Q2 2018 Aug 15, 2018	BUY	$32.98 - $35.16 $6.52 Million - $6.95 Million	197,684 Added 493.85%	237,713 $8.63 Million
Q1 2018 May 15, 2018	BUY	$31.91 - $37.02 $211,690 - $245,590	6,634 Added 19.87%	40,029 $1.42 Million
Q4 2017 Feb 12, 2018	SELL	$33.26 - $35.29 $386,447 - $410,034	-11,619 Reduced 25.81%	33,395 $1.21 Million
Q3 2017 Nov 13, 2017	BUY	$31.0 - $34.15 $1.4 Million - $1.54 Million	45,014	45,014 $1.61 Million

Others Institutions Holding PFE

# of Institutions

3,258

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Argent Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Argent Trust CO with notifications on news.

Account